(PRMB) Primo Brands - Overview
Sector: Consumer DefensiveIndustry: Beverages - Non-Alcoholic | Exchange NYSE (USA) | Currency USD | Market Cap: 6.725m | Total Return -44% in 12m
Stock: Water, Beverages, Dispensers, Filtration
Total Rating 35
Risk 44
Buy Signal -1.12
| Risk 5d forecast | |
|---|---|
| Volatility | 33.3% |
| Relative Tail Risk | -9.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.14 |
| Alpha | -47.88 |
| Character TTM | |
|---|---|
| Beta | 0.188 |
| Beta Downside | 0.469 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.12% |
| CAGR/Max DD | 0.18 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 88.1429
Description: PRMB Primo Brands March 05, 2026
Primo Brands Corporation (PRMB) is a North American beverage company. It provides water solutions through dispensers, direct delivery, water exchange programs, and filtration appliances. The company also operates self-service refill stations. The beverage sector is characterized by intense competition and evolving consumer preferences for healthy and sustainable options.
PRMBs brand portfolio includes natural spring water brands like Poland Spring and Arrowhead, purified water brands such as Primo Water, and flavored/enhanced options like AC+ION. The company employs a diversified business model, distributing products through direct-to-consumer, retail, residential, eCommerce, on-premise, and commercial channels.
To deepen your understanding of PRMBs market position, consider exploring its growth drivers and competitive landscape on ValueRay.
Headlines to watch out for
- Bottled water sales growth drives revenue
- Fuel and logistics costs impact profitability
- Regulatory changes threaten water sourcing
- Consumer health trends boost premium water demand
- Residential and commercial delivery demand fluctuates
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 60.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.92 > 1.0 |
| NWC/Revenue: -0.97% < 20% (prev 2.70%; Δ -3.67% < -1%) |
| CFO/TA 0.06 > 3% & CFO 688.8m > Net Income 60.1m |
| Net Debt (5.35b) to EBITDA (1.08b): 4.94 < 3 |
| Current Ratio: 0.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (374.9m) vs 12m ago 19.81% < -2% |
| Gross Margin: 30.13% > 18% (prev 0.35%; Δ 2.98k% > 0.5%) |
| Asset Turnover: 61.15% > 50% (prev 38.94%; Δ 22.21% > 0%) |
| Interest Coverage Ratio: 1.44 > 6 (EBITDA TTM 1.08b / Interest Expense TTM 326.5m) |
Altman Z'' -0.65
| A: -0.01 (Total Current Assets 1.22b - Total Current Liabilities 1.28b) / Total Assets 10.60b |
| B: -0.19 (Retained Earnings -2.01b / Total Assets 10.60b) |
| C: 0.04 (EBIT TTM 471.5m / Avg Total Assets 10.90b) |
| D: -0.27 (Book Value of Equity -2.02b / Total Liabilities 7.61b) |
| Altman-Z'' Score: -0.65 = B |
Beneish M -2.85
| DSRI: 0.64 (Receivables 431.8m/444.0m, Revenue 6.66b/4.36b) |
| GMI: 1.17 (GM 30.13% / 35.28%) |
| AQI: 1.01 (AQ_t 0.63 / AQ_t-1 0.62) |
| SGI: 1.53 (Revenue 6.66b / 4.36b) |
| TATA: -0.06 (NI 60.1m - CFO 688.8m) / TA 10.60b) |
| Beneish M-Score: -2.85 (Cap -4..+1) = A |
What is the price of PRMB shares?
As of March 27, 2026, the stock is trading at USD 18.42 with a total of 3,358,200 shares traded.
Over the past week, the price has changed by -6.83%, over one month by -5.65%, over three months by +11.51% and over the past year by -43.97%.
Over the past week, the price has changed by -6.83%, over one month by -5.65%, over three months by +11.51% and over the past year by -43.97%.
Is PRMB a buy, sell or hold?
Primo Brands has received a consensus analysts rating of 4.56.
Therefore, it is recommended to buy PRMB.
- StrongBuy: 5
- Buy: 4
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PRMB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.8 | 45.7% |
| Analysts Target Price | 26.8 | 45.7% |
PRMB Fundamental Data Overview March 26, 2026
P/E Trailing = 88.1429
P/E Forward = 13.9082
P/S = 1.0092
P/B = 2.2121
Revenue TTM = 6.66b USD
EBIT TTM = 471.5m USD
EBITDA TTM = 1.08b USD
Long Term Debt = 5.08b USD (from longTermDebt, last quarter)
Short Term Debt = 166.2m USD (from shortTermDebt, last quarter)
Debt = 5.73b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.35b USD (from netDebt column, last quarter)
Enterprise Value = 12.07b USD (6.73b + Debt 5.73b - CCE 376.9m)
Interest Coverage Ratio = 1.44 (Ebit TTM 471.5m / Interest Expense TTM 326.5m)
EV/FCF = 38.87x (Enterprise Value 12.07b / FCF TTM 310.7m)
FCF Yield = 2.57% (FCF TTM 310.7m / Enterprise Value 12.07b)
FCF Margin = 4.66% (FCF TTM 310.7m / Revenue TTM 6.66b)
Net Margin = 0.90% (Net Income TTM 60.1m / Revenue TTM 6.66b)
Gross Margin = 30.13% ((Revenue TTM 6.66b - Cost of Revenue TTM 4.66b) / Revenue TTM)
Gross Margin QoQ = 26.88% (prev 29.91%)
Tobins Q-Ratio = 1.14 (Enterprise Value 12.07b / Total Assets 10.60b)
Interest Expense / Debt = 1.39% (Interest Expense 79.4m / Debt 5.73b)
Taxrate = 44.55% (64.6m / 145.0m)
NOPAT = 261.4m (EBIT 471.5m * (1 - 44.55%))
Current Ratio = 0.95 (Total Current Assets 1.22b / Total Current Liabilities 1.28b)
Debt / Equity = 1.91 (Debt 5.73b / totalStockholderEquity, last quarter 2.99b)
Debt / EBITDA = 4.94 (Net Debt 5.35b / EBITDA 1.08b)
Debt / FCF = 17.22 (Net Debt 5.35b / FCF TTM 310.7m)
Total Stockholder Equity = 3.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.55% (Net Income 60.1m / Total Assets 10.60b)
RoE = 1.89% (Net Income TTM 60.1m / Total Stockholder Equity 3.18b)
RoCE = 5.70% (EBIT 471.5m / Capital Employed (Equity 3.18b + L.T.Debt 5.08b))
RoIC = 3.16% (NOPAT 261.4m / Invested Capital 8.28b)
WACC = 3.94% (E(6.73b)/V(12.45b) * Re(6.64%) + D(5.73b)/V(12.45b) * Rd(1.39%) * (1-Tc(0.45)))
Discount Rate = 6.64% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 52.82%
[DCF] Terminal Value 88.44% ; FCFF base≈358.6m ; Y1≈442.4m ; Y5≈754.8m
[DCF] Fair Price = 45.57 (EV 21.90b - Net Debt 5.35b = Equity 16.55b / Shares 363.2m; r=6.0% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 69.99 | EPS CAGR: 32.70% | SUE: 1.22 | # QB: 2
Revenue Correlation: 81.30 | Revenue CAGR: 33.49% | SUE: N/A | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.35 | Chg7d=-0.001 | Chg30d=-0.018 | Revisions Net=-2 | Analysts=12
EPS current Year (2026-12-31): EPS=1.31 | Chg7d=+0.016 | Chg30d=-0.009 | Revisions Net=-1 | Growth EPS=-1.6% | Growth Revenue=+0.4%
EPS next Year (2027-12-31): EPS=1.55 | Chg7d=-0.003 | Chg30d=-0.096 | Revisions Net=-1 | Growth EPS=+18.6% | Growth Revenue=+3.5%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 7.9% - Earnings Yield 1.1%)
[Growth] Growth Spread = -6.1% (Analyst 0.7% - Implied 6.8%)
P/E Forward = 13.9082
P/S = 1.0092
P/B = 2.2121
Revenue TTM = 6.66b USD
EBIT TTM = 471.5m USD
EBITDA TTM = 1.08b USD
Long Term Debt = 5.08b USD (from longTermDebt, last quarter)
Short Term Debt = 166.2m USD (from shortTermDebt, last quarter)
Debt = 5.73b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.35b USD (from netDebt column, last quarter)
Enterprise Value = 12.07b USD (6.73b + Debt 5.73b - CCE 376.9m)
Interest Coverage Ratio = 1.44 (Ebit TTM 471.5m / Interest Expense TTM 326.5m)
EV/FCF = 38.87x (Enterprise Value 12.07b / FCF TTM 310.7m)
FCF Yield = 2.57% (FCF TTM 310.7m / Enterprise Value 12.07b)
FCF Margin = 4.66% (FCF TTM 310.7m / Revenue TTM 6.66b)
Net Margin = 0.90% (Net Income TTM 60.1m / Revenue TTM 6.66b)
Gross Margin = 30.13% ((Revenue TTM 6.66b - Cost of Revenue TTM 4.66b) / Revenue TTM)
Gross Margin QoQ = 26.88% (prev 29.91%)
Tobins Q-Ratio = 1.14 (Enterprise Value 12.07b / Total Assets 10.60b)
Interest Expense / Debt = 1.39% (Interest Expense 79.4m / Debt 5.73b)
Taxrate = 44.55% (64.6m / 145.0m)
NOPAT = 261.4m (EBIT 471.5m * (1 - 44.55%))
Current Ratio = 0.95 (Total Current Assets 1.22b / Total Current Liabilities 1.28b)
Debt / Equity = 1.91 (Debt 5.73b / totalStockholderEquity, last quarter 2.99b)
Debt / EBITDA = 4.94 (Net Debt 5.35b / EBITDA 1.08b)
Debt / FCF = 17.22 (Net Debt 5.35b / FCF TTM 310.7m)
Total Stockholder Equity = 3.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.55% (Net Income 60.1m / Total Assets 10.60b)
RoE = 1.89% (Net Income TTM 60.1m / Total Stockholder Equity 3.18b)
RoCE = 5.70% (EBIT 471.5m / Capital Employed (Equity 3.18b + L.T.Debt 5.08b))
RoIC = 3.16% (NOPAT 261.4m / Invested Capital 8.28b)
WACC = 3.94% (E(6.73b)/V(12.45b) * Re(6.64%) + D(5.73b)/V(12.45b) * Rd(1.39%) * (1-Tc(0.45)))
Discount Rate = 6.64% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 52.82%
[DCF] Terminal Value 88.44% ; FCFF base≈358.6m ; Y1≈442.4m ; Y5≈754.8m
[DCF] Fair Price = 45.57 (EV 21.90b - Net Debt 5.35b = Equity 16.55b / Shares 363.2m; r=6.0% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 69.99 | EPS CAGR: 32.70% | SUE: 1.22 | # QB: 2
Revenue Correlation: 81.30 | Revenue CAGR: 33.49% | SUE: N/A | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.35 | Chg7d=-0.001 | Chg30d=-0.018 | Revisions Net=-2 | Analysts=12
EPS current Year (2026-12-31): EPS=1.31 | Chg7d=+0.016 | Chg30d=-0.009 | Revisions Net=-1 | Growth EPS=-1.6% | Growth Revenue=+0.4%
EPS next Year (2027-12-31): EPS=1.55 | Chg7d=-0.003 | Chg30d=-0.096 | Revisions Net=-1 | Growth EPS=+18.6% | Growth Revenue=+3.5%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 7.9% - Earnings Yield 1.1%)
[Growth] Growth Spread = -6.1% (Analyst 0.7% - Implied 6.8%)